GME Logo

User login

User menu

GME Meeting Planner

Tardive Dyskinesia Revisited

Overview



Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.

This activity is supported by an independent educational grant from Neurocrine Biosciences.

GME is not taking registrations for this event, please visit the AACP's registration page to RSVP: http://www.cvent.com/d/m7qm04/4W?RefID=GME 

 

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists and psychologists engaged in the care of patients with tardive dyskinesia.

 

Educational Objectives

After completing this activity, the participant should be better able to:

·Discuss the diagnostic issues and risk factors for TD

·Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics

·Formulate appropriate treatment strategies including new FDA approved treatments for TD

 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number –JA4008162-9999-20-2192-L01-P

Type of Activity: Application

 

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour. Designated for 0.4 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

 

California Board of Registered Nursing

Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1 contact hour.

 

AAPA Credit Designation Statement

This activity is designated for 1 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

 

Continuing Psychologist Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP).  The APA CEP Office maintains responsibility of the program.

Credit Designation

This program offers 1.0 continuing education credits for psychologists.

 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

 

Program Agenda

9:15 - 9:20 AM: Welcoming Remarks  - Henry Nasrallah, MD
9:20 - 9:40 AM: "Evaluating Psychiatric Patients for TD" - Henry Nasrallah, MD
9:40 - 10:00 AM: "Treatment Strategies for TD" - Jonathan Meyer, MD
10:00 - 10:15 AM: Q&A

Faculty Members Scheduled to Attend

Jonathan Meyer, MD
Clinical Professor of Psychiatry, University of California, San Diego
Henry Nasrallah, MD
Director, Neuropsychiatry and Schizophrenia Programs, University of Cincinnati College of Medicine

Location and Date

THURSDAY, AUGUST 13, 2020
Live Virtual Webcast
,

GME is not taking registrations for this meeting. Please see information on registration in the "Program Overview" section.

Join GME for Free!

Become a GME subscriber and gain full access to our extensive library of 700+ psychiatric medical education videos,
free CME webcasts, latest research updates, and more. To sample our content, watch the featured videos below.
Join Today!

GME Activities Calendar

AUGUST 13, 2020: 6:30pm-7:30pm (EST)
Tardive Dyskinesia Revisited
AUGUST 15, 2020: 11:00am-12:00pm (EST)
Managing Behavioral Disturbances in Dementia
AUGUST 26, 2020: 7:00pm-8:00pm (EST)
Innovative Approaches to Manage Difficult to Treat Depression
SEPTEMBER 01, 2020: 7:00pm-8:00pm (EST)
Managing Tardive Dyskinesia in the Real World
NEW DATE
SEPTEMBER 12, 2020: 5:30pm-7:00pm (EST)
Innovative Strategies to Treat Schizophrenia
SEPTEMBER 12, 2020: 3:50pm-5:20pm (EST)
An Evidence-Based Approach to ADHD
SEPTEMBER 26, 2020: 11:00am-6:00pm (EST)
Psychiatry Update 2020
SOLD OUT
OCTOBER 03, 2020: 9:00am-4:00pm (EST)
Psychiatry Update 2020
SOLD OUT
OCTOBER 10, 2020: 9:00am-4:00pm (EST)
Psychiatry Update 2020
OCTOBER 17, 2020: 9:00am-4:00pm (EST)
Psychiatry Update 2020
SOLD OUT
OCTOBER 24, 2020: 11:00am-6:00pm (EST)
Psychiatry Update 2020
SOLD OUT
NOVEMBER 20-21, 2020
Seventh Annual Mood Disorders Summit
DECEMBER 04-05, 2020
Sixth Annual Psychopharmacology Update

To contact GME, email us at [email protected]


GME does not provide medical advice. The website and articles are intended for informational purposes only. They are not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the GME Website. If you think you may have a medical emergency, immediately call your doctor or dial 911.

Log In

Join GME For Free

Become a GME subscriber and gain full access to our extensive library of 700+ psychiatric medical education videos, free CME webcasts, latest research updates, and more. To sample our content, watch the featured videos below.
Join Today!